Marine peptides in breast cancer: Therapeutic and mechanistic understanding

Salman Ahmed, Hamed Mirzaei, Michael Aschner, Ajmal Khan, Ahmed Al-Harrasi, Haroon Khan

Research output: Contribution to journalReview articlepeer-review

22 Scopus citations


Breast cancer is the most prevalent invasive form of cancer in females and posing a great challenge for overcoming disease burden. The growth in global cancer deaths mandates the discovery of new efficacious natural anti-tumor treatments. In this regard, aquatic species offer a rich supply of possible drugs. Studies have shown that several marine peptides damage cancer cells by a broad range of pathways, including apoptosis, microtubule balance disturbances, and suppression of angiogenesis. Traditional chemotherapeutic agents are characterized by a plethora of side effects, including immune response suppression. The discovery of novel putative anti-cancer peptides with lesser toxicity is therefore necessary and timely, especially those able to thwart multi drug resistance (MDR). This review addresses marine anti-cancer peptides for the treatment of breast cancer.

Original languageEnglish (US)
Article number112038
JournalBiomedicine and Pharmacotherapy
StatePublished - Oct 2021


  • Apoptosis
  • Cell cycle arrest
  • Marine peptides
  • Metastasis
  • Protein hydrolysate

ASJC Scopus subject areas

  • Pharmacology


Dive into the research topics of 'Marine peptides in breast cancer: Therapeutic and mechanistic understanding'. Together they form a unique fingerprint.

Cite this